Charles River Associates (CRAI) Q2 2026 earnings review

Record Revenues Mask Severe Cash Flow and Debt Deterioration

CRA delivered a beat on the top line, with Q2 revenue accelerating 12.8% YoY to a record $210.8M. The company continues to capitalize on strong M&A and regulatory demand, leading management to raise FY26 revenue guidance to $805M-$820M. However, aggressive talent acquisition is severely distorting the company's financial profile. While reported Net Income rose 11.4%, GAAP operating cash flow was negative (-$4.4M), driven by massive cash outlays for consultant sign-on bonuses ('forgivable loans'). Consequently, CRA's revolver balance has ballooned to $219M, forcing a mid-year credit facility expansion.

🐂 Bull Case

Broad-Based Demand Acceleration

Top-line momentum is undeniable. Eight practices grew YoY, with six posting double-digit gains. International operations surged 32.9% YoY, proving CRA's geographic diversification strategy is working.

High Utilization and Headcount Growth

Despite aggressive hiring, utilization expanded to 77% (from 76% a year ago). The company is successfully deploying its new, highly compensated senior talent into immediate billable work.

🐻 Bear Case

Deteriorating Earnings Quality

GAAP Net Income of $13.5M completely masks the -$4.4M operating cash flow drain this quarter. Over $19.6M in cash was advanced to consultants as forgivable loans, a structural cost of doing business that bypasses traditional EBITDA.

Leverage Spiking to Fund Operations

CRA's reliance on its revolving credit facility is rising at an alarming rate. Outstanding revolver borrowings hit $219M at the end of Q2, up from $120M a year ago, straining the balance sheet to fund talent and buybacks.

⚖️ Verdict: ⚪

Neutral. The underlying business demand is excellent, and revenue growth is accelerating. However, the cash cost of acquiring talent is creating a massive divergence between reported earnings and actual cash generation, forcing the company to increase debt to fund share repurchases.

Key Themes

DRIVER 🟢

International and Management Consulting Surging

Geographic and service line mix shifts are accelerating. International operations grew 32.9% YoY in Q2 (up from 20.3% in Q1), vastly outpacing North America's 8.7% growth. Concurrently, Management Consulting revenue jumped 25.5%, providing strong diversification against the Legal & Regulatory segment (+10.1%).

CONCERN NEW 🔴

Net Income vs Cash Flow Divergence

Reversing trend. Management reported record Q2 profits of $13.5M, yet GAAP operating cash flow was negative $4.4M (compared to positive $5.9M a year ago). This stark contradiction is entirely driven by CRA's talent acquisition model: the firm handed out $19.6M in cash as 'forgivable loan advances' this quarter to recruit and retain senior consultants. These cash outlays drag cash flow immediately but hit the P&L slowly over time.

CONCERN NEW 🔴

Debt Accumulation and Interest Headwinds

To fund its aggressive talent investments and stock repurchases ($27.8M in Q2), CRA is leaning heavily on debt. Revolving line of credit borrowings skyrocketed to $219M, up from $192M in Q1 and $120M a year ago. Consequently, net interest expense accelerated to $3.0M this quarter (up from $1.8M in 25Q2), creating a direct headwind to net income margins. The company had to refinance and expand its credit facility to $400M to accommodate this strategy.

THEME

AI as a Demand Amplifier, Not a Threat

Management continues to position Artificial Intelligence integration as a productivity enhancer rather than a disruptive risk to billable hours. CRA views AI as a tool to handle massive data sets, which in turn increases the complexity of client questions and drives demand for the firm's premium expert judgment. This is reflected in the sustained high utilization rate (77%) despite widespread market fears of AI displacing consulting hours.

DRIVER 🟢

Macro Tailwinds in M&A and Litigation

The external environment remains highly supportive. The Antitrust & Competition Economics practice posted a new quarterly revenue high, capitalizing on elevated global M&A scrutiny and complex regulatory landscapes. Continued strength in Forensics and Life Sciences further validates that corporate clients are facing high-stakes regulatory environments requiring CRA's specialized services.

CONCERN

Amortization Drag on GAAP Margins

Forgivable loan amortization (the deferred expense of talent acquisition) reached $14.9M in Q2, representing 7.0% of revenue—up from 5.5% a year ago. Management previously warned this non-cash expense would rise by $15M for the full year. This structural dynamic ensures GAAP operating margins will remain depressed relative to the firm's top-line growth trajectory.

Other KPIs

Share Repurchases (26Q2) $27.8 million

Accelerating. The firm repurchased 193,000 shares at an average price of $144. This is a significant increase from Q1's $21.5M outlay, reflecting management's conviction in the stock despite relying on debt to fund the purchases.

Days Sales Outstanding (DSO) 113 Days

Decelerating/Deteriorating slightly. DSO increased from 110 days in 25Q2 and 100 days in 26Q1. The mix shifted toward higher unbilled receivables (45 days unbilled vs 37 days a year ago), indicating a slight slowdown in invoicing cycles or larger, longer-term milestone projects.

Non-GAAP SG&A Excluding Commissions 15.5% of Revenue

Improving. SG&A ex-commissions dropped from 16.3% in 25Q2, demonstrating solid core operating leverage as top-line revenue scales faster than overhead expenses.

Guidance

FY26 Revenue (Constant Currency) $805 - $820 million

Accelerating. The company raised the range from the previous $785-$805M. Using the midpoint ($812.5M), this implies an 8.1% YoY growth rate compared to FY25's $751.6M. This is particularly impressive given FY26 is a 52-week year facing a 53-week comparison in FY25, plus an expected $2.5M FX drag.

FY26 Non-GAAP EBITDA Margin (Constant Currency) 12.0% - 13.0%

Stable. The margin guidance was reaffirmed. While revenue is over-performing, the flow-through to EBITDA margin is being capped by the aggressive talent acquisition strategy and associated bonus costs.

Key Questions

Leverage and Capital Allocation Limits

With the revolver balance up nearly $100M YoY to $219M and operating cash flow currently negative, is there a ceiling to how much debt the firm is willing to carry to fund share repurchases and upfront talent acquisition?

Unbilled Receivables Growth

Unbilled DSO ticked up significantly to 45 days. Is this a function of taking on larger, milestone-heavy engagements in the Management Consulting segment, or are there delays in client acceptance?

International Sustainability

International revenue grew nearly 33% this quarter. How much of this is driven by European antitrust/regulatory engagements, and do you foresee the impending U.S. election outcome altering cross-border M&A dynamics?

Peak Forgivable Loan Amortization

Forgivable loan amortization hit 7.0% of revenue this quarter. Assuming headcount growth begins to normalize, when do you expect this metric to peak as a percentage of revenue?